Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Baricitinib may effectively treat lichen planopilaris.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Upadacitinib may effectively treat resistant lichen planopilaris.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Intralesional triamcinolone acetonide effectively treats acne keloidalis nuchae with minimal side effects.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Itraconazole effectively treats scalp fungus, with continuous use more effective than pulse therapy.

AVT is highly conserved and may have antimicrobial properties.

Axitinib treatment turned a man's grey hair back to black.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

The combination therapy was effective and well-tolerated, especially in young patients.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.